[ad_1]
The post describes the deal as “fundamentally flawed.”
Negotiations on the supply of Sputnik V to Germany are taking longer and longer, sources in the publication explained. According to them, Russia will not be able to supply the vaccine in June and July due to a shortage of raw materials.
“Another hurdle: if Russia could deliver the Sputnik V vaccine to Germany in the summer, it should be at the expense of the planned doses to be sent to India. This shipment should be reduced,” writes Bild, quoted by rbc.ru. The German government does not doubt that this would be impossible “given the situation in India”.
Furthermore, the publication reports that the requirements for European regulators to approve the use of the Sputnik V vaccine in the European Union are much higher than “expected in Moscow.”
At the time, the Russian direct investment fund RBK claimed that negotiations with the German authorities on the purchase of the Russian vaccine “Sputnik V” were continuing and that the information that they were at a dead end was incorrect.
“The information in Bild is false, an example of a disinformation campaign aimed at preventing Russian vaccines and the like from entering Europe and other markets. The daily Bild has recently published more than 15 such articles attacking the Sputnik V vaccine. “These articles present incorrect facts based on information from anonymous sources,” the Russian direct investment fund said in a comment.
“Negotiations with Germany on the purchase of vaccines continue, the Sputnik V vaccine can be supplied to Germany as early as June this year, the supply of the vaccine to other countries would not be affected,” emphasizes the Russian Direct Investment Fund.
“There is an active and widely funded campaign against the Russian vaccine, the aim of which is to discredit the Russian vaccine in several countries. <...> There have been a number of cases in the history of the pharmaceutical industry in which large companies have used the media to attack competitors in order to create and exploit monopolistic positions in the markets. We believe that information wars against vaccines are unethical and undermine necessary vaccination efforts around the world, ”summarized the comment from the Russian Direct Investment Fund.
In early April, it was reported that German Health Minister Jens Spahn had announced bilateral talks with Russia about the possible purchase of the Sputnik V vaccine if the drug is registered in the European Union (EU).
The minister stressed that the vaccine must first be registered in the EU. “For that to happen, Russia needs to provide data,” he said.
The second issue then, according to Mr. Spahn, will be the order for the vaccine. The European Commission has stated that it will not enter into contracts for Sputnik V, as with other vaccine manufacturers such as Biontech / Pfizer. “Then I and the EU Council of Health Ministers said that we would have bilateral talks with Russia and first and foremost about when, in general, and in what quantities,” Spahn said.
According to him, depending on the situation, it is important that shipments reach Germany “in the next two to four, five months, otherwise we will have more than enough vaccine anyway.”
Therefore, strong promises are expected from Russia “when and in what quantities could they reach Germany after registration”.
Thomas Mertens, chairman of the German Standing Vaccine Commission (STIKO), told Zorg’s Morgenmagazin that the published data on the Sputnik V vaccine “looks very good.” However, he added that he did not know what additional information the European Medicines Agency (EMA) had.
“If the vaccine is tested and registered, I personally would have nothing against it,” emphasized the expert.
It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to cite DELFI as the source. .
[ad_2]
